This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
THELMA Therapeutics Co., Ltd. announced that it has received KRW 4.779985 billion in funding from AirQ Holdings Inc. CI
THELMA Therapeutics Co., Ltd. announced that it has received KRW 10.220014 billion in funding from AirQ Holdings Inc. and other investors. CI
THELMA Therapeutics Co., Ltd. cancelled the transaction announced on December 16, 2021 CI
Tranche Update on THELMA Therapeutics Co., Ltd.'s Equity Buyback Plan announced on January 5, 2023. CI
THELMA Therapeutics Co., Ltd.'s Equity Buyback announced on January 5, 2023, has closed with 195,868 shares. CI
THELMA Therapeutics Co., Ltd. announces an Equity Buyback for 195,868 shares. CI
THELMA Therapeutics Co., Ltd. authorizes a Buyback Plan. CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Thelma Therapeutics to Raise $7.3 Million via Stock Offering MT
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 9.9999998 billion in funding from AirQ Holdings Inc. CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 4.9999999 billion in funding from AirQ Holdings Inc. CI
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 4.9999999 billion in funding CI
THELMA Therapeutics Co., Ltd. announced that it has received KRW 2.8 billion in funding CI
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 4.9999999 billion in funding CI
THELMA Therapeutics Co., Ltd. announced that it has received KRW 4.9999999 billion in funding CI
Thelma Therapeutics to Raise $5.1 Million via Stock Sale MT
THELMA Therapeutics Co., Ltd. announced that it expects to receive KRW 2 billion in funding CI
THELMA Therapeutics Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Chart THELMA Therapeutics Co., Ltd.
More charts
EcoVive Co Ltd, formerly Thelma Therapeutics Co Ltd, is a Korea-based company that primarily sells gift certificates. The Company sells gift certificates wholesale and retail to individual and corporate customers. Additionally, the Company is engaged in the business of consulting on issuance and distribution procedures to companies wishing to issue gift certificates.
More about the company
  1. Stock Market
  2. Equities
  3. A015540 Stock
  4. News THELMA Therapeutics Co., Ltd.
  5. Thelma Therapeutics to Raise $7.3 Million via Stock Offering